PTI-2 (SGT-49) is an indole-based synthetic cannabinoid.[1] It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-1. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck.[2][3][4]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number |
|
ChemSpider |
|
UNII |
|
Chemical and physical data | |
Formula | C23H33N3OS |
Molar mass | 399.60 g·mol−1 |
3D model (JSmol) |
|
| |
|